CFTC gives the green light! US stock "perpetual contracts" land in the United States, Cboe and CME are anxious
CFTC approves stock perpetual contract trading, with Kalshi launching targets such as Amgen and McDonald's ahead of others; Cboe and CME file lawsuits in opposition, while Warren warns that this may cause market volatility.
Smart Finance APP has noted that a so-called perpetual derivative contract linked to stocks has received approval from the U.S. Commodity Futures Trading Commission (CFTC) and has been authorized to begin trading.
CFTC Chairman Michael Selig stated in a Tuesday announcement that these perpetual futures contracts will be classified as security futures and will be overseen by both the CFTC and the U.S. Securities and Exchange Commission (SEC). An industry body has already filed a lawsuit challenging this decision, while Kalshi launched several such contracts on the same day.
Perpetual contracts (perps) are leveraged contracts without an expiration date, differing from traditional derivatives. They can be traded around the clock, including when the stock markets are normally closed. This structure has made them popular overseas, although critics warn they also pose significant risks to inexperienced traders.
Selig said the CFTC's decision "marks an important step toward allowing U.S. market participants to utilize the advantages of perpetual futures under applicable laws—advantages that have made them highly coveted risk management and price discovery tools."
This move is unpopular in some parts of the trading industry, with complaints that the CFTC approved perpetual contracts without proper procedures.
Cboe Global Markets (CBOE.US) CEO Craig Donohue stated: "Single-stock perpetual derivatives are the latest example of a disturbing trend where securities products are being offered on CFTC platforms outside of the proper regulatory framework and customer protections established by Congress."
The Capital Markets Coalition, representing Cboe, Citadel Securities, and other U.S. exchanges, trading firms, and investor advocacy groups, has petitioned a federal court in New York to halt the trading of perpetual contracts. The industry group argued that the CFTC did not comply with the Administrative Procedure Act in approving these new products.
After the lawsuit was filed, the CFTC did not immediately respond to requests for comment. The regulator has made bringing perpetual contracts to regulated U.S. markets a priority, including approving the first crypto perpetual contracts earlier this year.
Prediction market company Kalshi sought CFTC regulatory approval in September to list single-stock perpetual contracts. These contracts have been under regulatory review until November 2.
The company began offering the first single-stock perpetual contracts tied to Amgen (AMGN.US), McDonald’s (MCD.US), Qualcomm (QCOM.US), and Costco (COST.US) later on Tuesday.
Kalshi spokesperson Jack Sach said: "We're bringing single-stock perps to the U.S. because we believe they make trading stock prices simpler, cheaper, and more efficient. Offshore traders love single-stock perps, and we're excited to bring that choice to the U.S."
Coinbase (COIN.US), Bitnomial, and other exchanges are also planning to offer these contracts.
Andy Rose, Head of Institutional Business at Kalshi, criticized the Capital Markets Coalition lawsuit.
Rose said during an interview at the FIA Expo in Chicago: "Monopolists love to litigate when facing competition."
Previous CFTC approvals of other types of perpetual contracts have already attracted legal action. The largest derivatives exchange, CME Group (CME.US), earlier this year sued the commission, arguing the regulator should treat these products as swaps rather than futures.
CME President and CFO Lynne Fitzpatrick stated at the futures industry conference that these products will "add more risk to the system," and even firms like CME that do not list these products could face risk contagion.
After the CFTC announced the decision on Tuesday, stocks in Cboe, CME, and Intercontinental Exchange (ICE.US) all declined.
Congressional Review
If the Democratic Party regains control of both the House and Senate, the CFTC's actions regarding perpetual contracts could face significant scrutiny from Congress.
In recent weeks, lawmakers from both parties have voiced concerns about these contracts. On October 29, Republican Senator Katie Britt of the Senate Banking Committee called for the SEC and CFTC to work together to ensure these products have adequate investor protections.
Elizabeth Warren, the Democratic lead on the Senate Banking Committee, slammed the CFTC’s decision just minutes after it was announced. In a statement, she said U.S. stock perpetual contracts "could inject severe volatility into our markets."
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Alcoa (AA.US): Subsequent resumption of production in the Middle East is expected to be more gradual, and new capacity planned before the war may be difficult to implement
Middle Eastern production resumption can increase supply, but the recovery speed depends on the actual economic viability of production.
Democrats achieve a landslide victory, global stock markets "plunge before rebounding," gold and silver surge—what is the market trading on?
Behind this "sharp drop followed by a rebound" in the market is a rational correction after the rapid repricing of the political landscape. Trump's veto power provides a two-way check and balance, making policy gridlock the most likely outcome, thus calming panic sentiment. However, the duration of election-driven market volatility has historically been limited; the future of the AI theme and geopolitical developments are the core variables driving the market towards the end of the year.
Astera Labs (ALAB.US) Q3 Conference Call: CFO responds to whether Scorpio X ramp-up can be sustained; CEO declares "Each generation of XPU doubles the content"
Astera Labs (ALAB.US) reported record Q3 revenue and guidance far exceeded expectations, yet its stock price dropped after hours. Management declined to comment on the customer ramp-up schedule for 2027, stating that new customers and platforms will drive continued growth.

Republicans Lost the Midterm Elections, $450 Million Down the Drain? "Big Donor" Musk Speaks Out: My Intervention Seems to Have Had No Effect
The Democratic Party achieved a sweeping victory in the US midterm elections, marking a defeat for Musk’s $445 million donation supporting the Republican Party. With the Democrats controlling Congress, uncertainty surrounding AI regulations and potential merger deals for Tesla and SpaceX is expected to intensify. Anticipation of stricter regulation for data centers in Texas is rising, putting post-market pressure on the stocks of Tesla, SpaceX, Nvidia, and CoreWeave.

